| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 57-87-4 | 麦角固醇; 麦角甾醇 | Ergosterol; (22E)-Ergosta-5,7,22-trien-3beta-ol; Provitamine D2 |  | C28H44O | 详情 | 供应商 |
| 58-49-1 | 血管紧张素 | Angiotensin acetate; Alanine,N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI); 1-Asp-5-Val-angiotensin II; 1-L-Asparticacid-5-valine-angiotensin II; 1-a-L-Aspartic acid-5-L-valine-angiotensin II; 11: PN: US20090227507 SEQID:20 unclaimed protein; 11: PN: US6762167 SEQID: 19 unclaimed sequence; 16: PN:WO0144270 SEQID: 19 claimed protein; 178: PN: WO2008004992 SEQID: 42 unclaimedsequence; 17: PN: US20080293634 SEQID: 24 unclaimed sequence; 17: PN: WO0143761SEQID: 19 claimed protein; 17: PN: WO0155176 SEQID: 19 claimed protein; 17: PN:WO02087504 SEQID: 19 claimed protein; 18: PN: WO0002905 SEQID: 19 claimedprotein; 18: PN: WO0198325 SEQID: 19 claimed protein; 19: PN: US20030130196SEQID: 19 claimed protein; 19: PN: WO0056345 SEQID: 19 claimed sequence; 23:PN: WO0069900 SEQID: 672 unclaimed sequence; 23: PN: WO9958140 SEQID: 19 claimedsequence; 24: PN: WO0069900 SEQID: 673 unclaimed sequence; 4: PN: WO0187976PAGE: 16 unclaimed sequence; 5-L-Valine angiotensin II; 5-Valine-angiotensinII; Angiotensin II(Alligator mississippiensis); Angiotensin II (ox); Angiotensin II 5-valine; L-Aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-L-phenylalanine; L-Phenylalanine, N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl-]-L-histidyl]-L-prolyl]-; Valine angiotensin II; [Val5] Angiotensin II, human; |  | C49H70N14O11 | 详情 | 供应商 |
| 470-37-1 | 蟾酥; 华蟾酥毒基 | Cinobufagin; 5b,20(22)-Bufadienolide-3b,16b-diol-14,15b-epoxy 16-acetate |  | C26H34O6 | 详情 | 供应商 |
| 502-41-0 | 环庚醇 | Cycloheptanol; Cycloheptylalcohol; NSC 52221; |  | C7H14O | 详情 | 供应商 |
| 976-56-7 | 抗氧剂1222; 3,5-二叔丁基-4-羟基苄基二乙基膦酸酯 | Diethyl 3,5-di-tert-butyl-4-hydroxybenzyl phosphate; Antioxidant 1222 |  | C19H33O4P | 详情 | 供应商 |
| 998-30-1 | 三乙氧基硅烷; TES | Triethoxysilane; CT2500; triethoxy-silan; Triethoxysilane ((C2H5O)3SiH); Triethoxysilicane; TRIETHOXYSILANE; Triethoxysilane,96%; Triethoxysilaneelectronicgradeavailable; Silane, triethoxy- |  | C6H16O3Si | 详情 | 供应商 |
| 5765-44-6 | 5-甲基异恶唑; 5-甲基异噁唑 | 5-Methylisoxazole; 5-Methylisoxazole; NSC 52269 |  | C4H5NO | 详情 | 供应商 |
| 23978-09-8 | 4,7,13,16,21,24-六氧-1,10-二氮双环[8.8.8]二十六烷 | Kryptofix 222; 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]-hexacosane |  | C18H36N2O6 | 详情 | 供应商 |
| 83915-83-7 | 赖诺普利; 1-[N2-((S)-羰基)-3-苯丙基]-L-赖氨酰基-L-脯氨酸 | Lisinopril; (S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate |  | C21H31O5N3.2(H2O) | 详情 | 供应商 |
| 93051-44-6 | C.I.活性蓝222 | C.I. Reactive blue 222; reactive blue 222 | 无 | C37H23ClN10O22S7.6Na | 详情 | 供应商 |
| 12032-97-2 | 锑化锰 | Antimony, compd. withmanganese (1:2); Manganeseantimonide (Mn2Sb) (6CI,7CI,8CI); Manganese, compd. with antimony (2:1) |  | Mn2Sb | 详情 | 供应商 |
| 53-73-6 | 增血压素 | Angiotensin II,1-L-asparagine-5-L-valine-; Alanine,N-[1-[N-[N-[N-[N-(N2-L-asparaginyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI); 1-Asn2-5-Val-angiotensin II; 1-Asparagine-5-valineangiotensin II; 1-Asparaginyl-5-valyl-angiotensin II; 1-Aspartic acid-5-valine angiotensin IIamide; 1-Aspartic acid-b-amide 5-valine angiotensin II; 1-L-Asn-5-L-Val-angiotensin II; 1-L-Asparagine-5-L-valineangiotensin II; 1-L-Asparagine-5-L-valine-angiotensin; 1-L-Asparaginyl-5-L-valyl angiotensin octapeptide; 1-a-Asparagine-5-valine-angiotensinII; 12: PN: US20090227507 SEQID: 21 unclaimed protein; 12: PN: US6762167 SEQID:20 unclaimed sequence; 17: PN: WO0144270 SEQID: 20 claimed protein; 18: PN:WO0143761 SEQID: 20 claimed protein; 18: PN: WO0155176 SEQID: 20 claimedprotein; 18: PN: WO02087504 SEQID: 20 claimed protein; 19: PN: WO0002905 SEQID:20 claimed protein; 19: PN: WO0198325 SEQID: 20 claimed protein; 20: PN:US20030130196 SEQID: 20 claimed protein; 20: PN: WO0056345 SEQID: 20 claimedsequence; 24: PN: WO9958140 SEQID: 20 claimed protein; 5-L-Valine-angiotensinII amide; 5-Valine angiotensin II amide; 5-Valine angiotensin II aspartic-b-amide; 5-Valine angiotensinamide II; 5-Valine-angiotensin II-b-amide; 5-Valyl angiotensin II amide; 545: PN: US20090175821 SEQID: 655claimed protein; 6: PN: WO0069900 SEQID: 655 unclaimed sequence; Angiotensin(Ciba); Angiotensin II (Oncorhynchus mykiss); Angiotensin II (eel); AngiotensinII amide; Angiotensin II amide 5-valine; Angiotensin II amide, 5-L-valine-; Angiotensin II aspartic-b-amide, 5-L-valine; Angiotensin II-5-valine-amide; Angiotensin amide; Angiotensin amide, 5-L-valine-; Hypertensin; Hypertensinamide; Hypertensine; Ipertensina; L-Phenylalanine,N-[1-[N-[N-[N-[N-(N2-L-asparaginyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-; NSC 107678; Rainbow trout angiotensin II; Val-Hypertensin-II-asp-b-amide; Val5-angiotensin II amide |  | C49H70N14O11 | 详情 | 供应商 |
| 25061-86-3 | Angiotensin II,5-L-isoleucine-8-L-alanine- (8CI,9CI); Alanine,N-[1-[N-[N-[N-[N-(N2-a-aspartylarginyl)valyl]tyrosyl]isoleucyl]histidyl]prolyl]- (6CI); 5-Isoleucine-8-alanineangiotensin; 5-Isoleucine-8-alanine-angiotensin II; 5-L-Isoleucine-8-L-alanineangiotensin II; 8-Ala-Ang II; [8-Alanine]-5-isoleucine-angiotensin II |  | C44H67N13O12 | 详情 | 供应商 | |
| 4474-91-3 | Angiotensin II,5-L-isoleucine-; Alanine,N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-isoleucyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI); 10: PN: WO0212471 SEQID: 17 unclaimed sequence; 113: PN:WO2008104000 TABLE: 4 unclaimed sequence; 11: PN: US20030119021 SEQID: 10unclaimed sequence; 1272: PN: US20050069911 SEQID: 1272 unclaimed sequence; 12:PN: US20090088553 SEQID: 86 unclaimed protein; 12: PN: WO0239997 SEQID: 17unclaimed sequence; 134: PN: WO02098448 SEQID: 144 unclaimed sequence; 134: PN:WO02098906 SEQID: 144 unclaimed sequence; 14: PN: WO2004007538 SEQID: 13claimed sequence; 154: PN: WO2009126292 TABLE: 4 unclaimed sequence; 17: PN:US6610497 SEQID: 17 unclaimed sequence; 17: PN: US6884771 SEQID: 17 unclaimedsequence; 17: PN: US6989363 SEQID: 17 unclaimed sequence; 17: PN: WO2006032674SEQID: 15 claimed sequence; 1: PN: CN101015689 SEQID: 1 claimed sequence; 1:PN: CN1706502 PAGE: 2 claimed sequence; 1: PN: US6022696 SEQID: 2 unclaimedsequence; 1: PN: WO0002905 SEQID: 1 claimed protein; |  | C50H71N13O12 | 详情 | 供应商 | |
| 14331-83-0 | Actinium, isotope ofmass 228; 228Ac; Ac228; Actinium-228; Mesothorium 2 |  | Ac | 详情 | 供应商 | |
| 4185-22-2 | Acetamidine,2,2-diphenyl-N'-p-tolyl- (7CI,8CI); NSC 22522 |  | C21H20N2 | 详情 | 供应商 | |
| 60305-22-8 | A'-Neo-30-norgammacerane,22-ethyl-, (17a,22R)-; (22R)-17a(H),21b(H)-Homohopane; 17a(H),21b(H),22R-Homohopane; 22R,17aH,21bH-30-Methylhopane; 22R,17aH,21bH-Homohopane |  | C31H54 | 详情 | 供应商 | |
| 53-75-8 | Angiotensin II, 1-L-b-aspartic acid-5-L-valine-(8CI,9CI); Alanine,N-[1-[N-[N-[N-[N-(N2-L-b-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-3-phenyl-(7CI); Alanine, N-[1-[N-[N-[N-[N-(N2-b-aspartylarginyl)valyl]tyrosyl]valyl]histidyl]prolyl]-3-phenyl-(6CI); 1-L-b-Aspartic acid 5-L-valineangiotensin II; 1-b-Asp-5-Val-angiotensin II; 1-b-L-Aspartic acid-5-L-valine-angiotensin II; Ciba 33902-Ba; L-Phenylalanine, N-[1-[N-[N-[N-[N-(N2-L-b-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-; b-1-L-Aspartic acid-5-valineangiotensin II; b-Aspartyl1-valyl5-angiotensinII |  | C49H69N13O12 | 详情 | 供应商 | |
| 34919-98-7 | Acetamide,2-[2-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenoxy]-N-methyl-; AI 27303; Cetamolol; ICI 72222 |  | C16H26N2O4 | 详情 | 供应商 | |
| 14265-85-1 | Actinium, isotope ofmass 225; 225Ac; Ac225; Actinium-225 |  | Ac | 详情 | 供应商 | |
